Koers LexaGene Holdings Inc.
Aandelen
LXXG.Q
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,18% | 8,24 mld. | |
+5,36% | 3,55 mld. | |
-1,60% | 2,28 mld. | |
-21,06% | 1,98 mld. | |
-24,15% | 1,64 mld. | |
+28,55% | 1,12 mld. | |
+26,92% | 803 mln. | |
-9,39% | 700 mln. | |
-25,31% | 575 mln. |